Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001477932-25-001919
Filing Date
2025-03-24
Accepted
2025-03-24 12:01:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4784
  Complete submission text file 0001477932-25-001919.txt   6609
Mailing Address #08-22 ONE COMMONWEALTH 1 COMMONWEALTH LANE U0 149544
Business Address #08-22 ONE COMMONWEALTH 1 COMMONWEALTH LANE U0 149544 603824911
CytoMed Therapeutics Ltd (Subject) CIK: 0001873093 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94045 | Film No.: 25763270
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 53 UBI CRESCENT SINGAPORE U0 408594
Business Address 53 UBI CRESCENT SINGAPORE U0 408594 6563478911
mDR Ltd (Filed by) CIK: 0001973616 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A